Orthopedic devices are designed to support a damaged bone or replace a missing bone or joint. These devices are mainly made of stainless steel. Manufacturers also employ titanium alloys for strength and plastic coating that acts as an artificial cartilage. Orthopedic devices have major demand across the globe due to the growing cases of road accidents along with rising geriatric population that is prone to various orthopedic diseases. Rods, pins, plates, and screws are some of the most commonly used orthopedic devices to support fractured or damaged bones. Request a Free Sample Copy of Orthopedic Devices Market Report @ https://www.radiantinsights.com/research/global-orthopedic-device-market-2018-2022/request-sample Orthopedic Devices to Witness High Demand through 2022 Major orthopedic devices are trauma fixation devices, spinal devices, arthroscopic devices, support system, and orthopedic accessories. The spinal devices are likely to have a steady growth over the forecast period on account of new product development and growing occurrences of degenerative disc diseases. Rising adoption of minimally invasive surgeries for the treatment of orthopedic disorders along with the growing availability of these devices in developing regions is projected to augment the growth of this segment. Trauma fixation devices are also projected to experience growth at a considerable rate during the forecast years. This growth can be attributed to the product innovations and high demand from various developing regions. Increased cases of road accidents and sports injuries are anticipated to further boost the demand for these devices. Increased consumer disposable income and growing awareness levels in various developed regions such as the UK and the US are also likely to contribute toward the increased demand. For further inquiries, about – Global Orthopedic Devices Market Analysis, Size, Growth, Trends and Forecast 2018 – 2022, click on this link – https://www.radiantinsights.com/research/global-orthopedic-device-market-2018-2022 Market Overview Based on the findings of a research study available on Radiant Insights, Inc.; the orthopedic devices market is likely to have rapid growth during the forecast period (2016 to 2022). Escalated demand for orthopedic surgeries, due to growing occurrences of orthopedic diseases and road accidents, are expected to propel market expansion in near future. Key companies in the market are Becker Orthopedic Appliance Co.; Comfortfit Orthotic Labs, Inc.; Otto Bock Holding GmbH & Co. KG; and Aspen Medical Products, Inc. Novel product development is the primary strategy followed by most key players to gain the top market position. For example, The Orthopaedic Implant Company launched their OIC External Fixation System in the recent past at the Annual Meeting of Orthopaedic Trauma Association (OTA, 2017). This new fixation tool features a multi-hole clamp option along with bent and straight posts. It also has a patent pending single clamp system that can enable bar-to-pin and bar-to-bar construction. To read more reports of this category, Visit our blog: https://pharmaceuticalandhealthcarereports.weebly.com
0 Comments
The global veterinary surgical instrument market is projected to attain huge revenue by 2022, according to a report available on Radiant Insights, Inc. It is anticipated to exhibit a steady CAGR over the forecast period (from 2012 to 2022). High rate of animal adoption and animal healthcare expenses are the key market drivers. Use of advanced veterinary (vet) surgical instruments in treating various animal diseases can positively impact market growth. Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/global-veterinary-surgical-instruments-sales-market-report-2017/request-sample Veterinary surgical instruments are the indispensable tools used for animal treatment and surgery. Various imaging devices and other such tools assist veterinarian technology assistants and veterinarians in diagnosis and treatment of zoonotic diseases. Population of pet cats decreased to nearly 74 million in 2011, while pet dog numbers declined to nearly 70 million in the same year. Lack of pet insurance has deterred pet owners from taking their respective animals to vets. However, development of ergonomic instruments can change this trend in the market over the forthcoming years. Vet instruments are being manufactured using tungsten carbide, rather than stainless steel for extended durability. They need to be cleaned on a regular basis to avoid corrosion and prevent the chances of infection. Spectrum Surgical Instruments Corporation, a US-based manufacturer, recently introduced an injection cannula set. It contains three pieces and is fabricated using stainless steel. The report “Global Veterinary Surgical Instruments Sales Market Report 2017” is available now at https://www.radiantinsights.com/research/global-veterinary-surgical-instruments-sales-market-report-2017 The worldwide veterinary surgical instrument market is segmented on the basis of product, animal, application, and region. By product, the market is divided into trocars & cannulas; hooks & retractors; sutures, staplers, and accessories; surgical scissors; scalpels; forceps; and others. ‘Others’ include electro surgery devices. Sutures, staples and accessories accounted for a large market share in 2015. Electro surgery devices on the other hand, are estimated to exhibit rapid growth during the forecast period. Several inherent features such as precision, rapid healing, and easy handling of electrode pencils can impel the demand. They find wide applications in the surgeries for small and large animals. As per animals, the market for veterinary surgical instruments is split into small and large animals. Small animals are sub-divided into canines, felines, and other animals. Equines and other large animals are subsumed within large animals. The spate of surgeries required to maintain racehorses and other large zoo animals are expected to positively impact demand over the years to come. Recently, a thoroughbred filly in Ireland was implanted with a scaffold to rebuild its jaw. Innovative applications can further boost the market expansion. Major market applications comprise ophthalmic, sterilization, orthopedic, soft-tissue, dental, gynecology & urology, and other surgeries. B. Braun Vet Care GmbH, one of the major manufacturers in animal dental care, provides a surgical instrumentation kit. It can find applications in jaw orthopedics, dental diagnostics, and conservation of teeth. Dental surgery is expected to exhibit remarkable growth in the near future due to prevalence of teeth maladies such as Feline Odontoclastic Resorptive Lesions (FORL) and parodontitis. Regional segmentation covers India, Japan, China, United States, Europe, and Southeast Asia. Europe is estimated to dominate the overall market followed by North America. Regions within Asia Pacific – Japan, China, and India, are anticipated to grow robustly during the forecast period. Large livestock population and mushrooming veterinary centers can propel the regional market. To read more reports of this category, Visit our blog: https://healthandpharamceuticalri.blogspot.com Key players operating in the veterinary surgical instruments market are Integra Lifesciences Holdings Corporation; Jorgensen Laboratories; Medtronic PLC; IM3 Inc.; and DRE Veterinary. Medtronic and Jorgensen are expected to continue dominating the global market till 2022. Acquisitions, novel products, and collaborations are the chief business strategies practiced by most companies to sustain market hold. Recently, Neogen Corporation acquired SyrVet Incorporated to enhance its own product portfolio. The distribution partnership of SyrVet with sheep, beef, dairy, and pork producers is expected to facilitate the former’s business expansion in the years ahead. Brain monitoring equipment market in the United States is projected to earn good revenue by 2022). It is expected to grow at a significant CAGR over the forecast period (from 2016 to 2022). Rising incidence of brain disorders such as multiple sclerosis, Alzheimer’s, and epilepsy is the key market driver.High demand from intensive care units is projected to further support the growth in the forthcoming years. Brain monitoring equipment can analyze abnormal brain waves. They assist in the neural and electrical activity within the brain. This can provide accurate readings to aid in medical diagnosis and course of treatment. The market is expected to witness steady rise in revenue in the forthcoming years. Revenue in the market has been sluggish due to the 2011 recession. However, technological advancements can cause positive impact on the global market. Request a Free Sample Copy of this Report @ www.radiantinsights.com/research/united-states-brain-monitoring-equipments-industry-2017/request-sample Advancements in brain monitoring devices have led to their implementation in post and perioperative settings. For instance, Cortical Dynamics Ltd., a specialist in these devices launched the Brain Anesthesia Monitor to check the effect of anesthesia on patients during presurgery. This could reduce insurance claims related to intra-operative awareness during surgeries. Portability is a feature that could reduce the prices of these devices. Rise in geriatric populace and consumer awareness can further contribute to market growth during the forecast period. The brain monitoring equipment market in the United States is segmented on the basis of types, applications, and regions. By types, the market is divided into Electroencephalography (EEG), Electromyography (EMG), Intracranial Pressure (ICP) monitors, Transcranial Doppler (TCD), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Magnetoencephalography (MEG), Computerized Tomography (CT), cerebral oximeters, and sleep monitoring devices. The report “United States Brain Monitoring Equipments Industry 2017 Market Research Report” is available now at https://www.radiantinsights.com/research/united-states-brain-monitoring-equipments-industry-2017 EEG devices are expected to dominate the overall market till 2022. Applications in the treatment of epilepsy and sleep disorders are anticipated to drive the market. MRI may exhibit a high CAGR on account of technological advantages over the years to come. Applications in staging and diagnosis of neurological disorders are expected to further support the demand in the forthcoming years. Major market applications encompass clinics & ambulatory surgery centers, hospitals, and others. Hospitals may lead the market on account of demand during the forecast period. Easy access to latest medical technologies is the key driver. High capacity to manage the inflow of patients as well as rapid installation of advanced brain monitoring equipment can further impel the expansion. Demand for cerebral oximeters and ICP monitors on account of growing cases of hypoxia can contribute to future market growth. Geographically, the brain monitoring equipment market is fragmented into the Midwest, West, Southwest, South, Middle Atlantic, and New England. Recently, Neuronetrix, a Kentucky-based company, received FDA approval for its portable EEG device dubbed ‘Cognision System’. This device allows doctors to undertake patient tests in a clinical setting. In addition, it is also found successful in testing the effects of trial drugs that can be beneficial for brain disorders. Major players operating in the United States market for brain monitoring equipment are Advanced Brain Monitoring, Natus Medical Incorporated, Siemens Healthineers, Philips Healthcare, and Medtronic Public Limited Company. Acquisitions and product innovations are the chief business expansion strategies incorporated by most companies to sustain market competition. To read more reports of this category, Visit our blog: https://medicaldevicesmarketreports.tumblr.com Philips Healthcare recently completed its acquisition of Electrical Geodesics to extend its product portfolio. Its existing imaging technology could play a major role in shaping future products. The combination of clinical informatics and mapping tools can allow the company to provide better solutions targeting patient care. Automated Peritoneal Dialysis (APD) is a modality of Peritoneal Dialysis (PD) which is performed by a machine during night time when the patient is asleep. It is also known as Continuous Cyclic Peritoneal Dialysis (CCPD). The system uses the peritoneal membrane of the patient to draw excess and waste fluid from blood.
How does it Work? In this, a machine performs dialysis, the process of removing excess water and other wastes from a patient’s body over a period of 9 to 10 hours. The machine determines the fluids required for each exchange and times its delivery, dwell, and drainage automatically. Approximate training time for this process is around ten days; after that patients can perform this process at home. Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/global-automated-peritoneal-dialysis-apd-industry-2017/request-sample New System for Home Dialysis Solution Generation Growing demand for home dialysis and other home-based treatments has resulted in various technological, as well as product innovations. Thus, a lot of APD system manufacturers are focusing on R&D activities to introduce innovative and easy-to-use systems. For example, Baxter International, Inc. is designing a new system for PD solution generation to produce at-home sterile peritoneal dialysis solutions. The new system is incorporated with AMIA APD system of the company and is designed to produce sterile PD solutions with the help of a small water filtration device at the patients’ homes. It is also said to decrease the weight and storage handling needs of the traditional PD solutions. According to the company, this system canoffer physicians the flexibility to prescribe different dextrose concentrations for every dwell cycle, based on individual requirements. The report “Global Automated Peritoneal Dialysis (APD) Industry 2017 Market Research Report” is available now at https://www.radiantinsights.com/research/global-automated-peritoneal-dialysis-apd-industry-2017 Market Overview Based on the findings of a new research report available on Radiant Insights, Inc.;the global Automated Peritoneal Dialysis (APD) market is likely to witness fast-paced growth over the forecast years (from 2017 to 2022).Growing private investments and venture funding that support novel product innovation are predicted to augment the market in near future. Moreover, increased government expenditure on healthcare driven by focus on the last-stage renal disease treatments is also anticipated to propel the global market over the next few years. High preference for home-based therapies is also projected to positively affect the market over the forecast period (2017 to 2022). The global APD market is dominated by various key companies including JMS Co., Ltd.; Baxter International Inc.; Terumo Medical Corp. (TMC); Diaverum Sweden AB; and Fresenius SE & Co. KGaA. About Radiant Insights, Inc Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake. Read more reports of this category @ medicaldevicesmarketreports.tumblr.com Increasing cases of chronic diseases such as cardiac disorders and cancers are expected to boost the demand for nuclear medicines owing to their extensive usage. In addition, need for accurate and early diagnostic procedures along with the high demand for advanced treatments may further augment the market growth in near future. High demand for Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) imaging is also one of the key market drivers. Moreover, increased awareness about PET/CT and SPECT/CT medical imaging technologies is projected to encourage the technological progression in the global market for nuclear medicine during the next few years.
Browse the Full Global Nuclear Medicine Market - Global Scenario, Industry Outlook, Analysis, Size, Trends and Forecast to 2021 Report at - https://www.radiantinsights.com/research/global-nuclear-medicine-market-report-and-forecast-to-2021 Rapid technological advancements, use of hybrid imaging, rise in public awareness, abundance of radio pharmaceuticals, and availability of a wide variety of products are also projected to propel the market in near future. In addition, growing therapeutic applications and replacement of traditional equipment may further boost market expansion over the forecast period. Factors such as high costs of processing and availability of limited stocks of nuclear medicines may hinder the growth of this market. However, positive industry trends such as production based on cyclotron and huge investments in research and development (R&D) and partnerships for the discovery of nuclear medicines are anticipated to help overcome these challenges in the next four years. Recently, Royal Philips showcased their latest solution and technology, Vereos Digital PET/CT that features their proprietary Digital Photon Counting (DPC) tech, at the SNMMI 2017 Annual Meeting. It offers enhanced diagnosis and quantification at half the PET dose. The global nuclear medicine market is categorized into product type, application, and region. Based on product type, the market is categorized into therapeutic, diagnostic, and type C. Based on application, the market is divided into neurology, oncology, and cardiology. Request a Free Sample Copy of Nuclear Medicine Market Report @ https://www.radiantinsights.com/research/global-nuclear-medicine-market-report-and-forecast-to-2021/request-sample Based on region, the market is segregated into Europe, North America, and Asia Pacific (APAC). North America dominated the global market in the past. Factors such as better reimbursement structure, well-planned policies, and high awareness and healthcare expenditure levels are expected to boost the regional growth in near future. On the other hand, the APAC regional market is anticipated to have lucrative growth over the next few years. Growth of this region can be attributed to the rising demand for nuclear medicines in various developing countries due to improving healthcare standards, increased disposable income, and reforms in foreign policies. Moreover, rising cases of neurological and cardiovascular diseases and population explosion in the region are also projected to fuel the APAC market. Some of the major companies operating in the global market for nuclear medicine include Toshiba Medical Systems Corp.; Bracco Imaging S.p.A.; GE Healthcare; Eckert & Ziegler Group; and Siemens Healthineers. Most key players have undertaken market strategies to obtain the maximum market share. These strategies include partnerships, mergers and acquisitions, global business expansion, and development of new product and/or technology. Among these, product development is the key strategy that can get more customers. Apart from these strategies, prominent market players have also heavily invested in research & development activities to discover advanced nuclear medicines. Rising per capita spending of consumers on healthcare can play a pivotal role in the development of the market over the forecast period (2017 to 2021). Surging use of specialty medicines and the flourishing growth of the pharmaceutical sector are anticipated to keep the demand high for active pharmaceutical ingredients.
Download Full Research Report @ https://www.radiantinsights.com/research/global-active-pharmaceutical-ingredients-market-report-and-forecast-to-2021 Growing geriatric population may also stoke the growth of the market. Since aged people are more susceptible to disorders such as type 2 diabetes, cancer, cardiovascular diseases, and high blood pressure, growth in their population is likely to expand the base of patients suffering from chronic diseases worldwide. This, in turn, can escalate the demand for APIs. Spiraling demand for rapid-acting and efficient drugs is also poised to augment the market in near future. Patent expirations of blockbuster drugs can translate into the greater uptake of generic versions of these drugs. This results in blockbuster drug manufacturers incurring a loss. Moreover, after a patent expires, R&D investments are no longer beneficial for the company, Hence; the trend of outsourcing is constantly increasing, thereby supporting the growth of the market. Request a Free Sample Copy of Active Pharmaceutical Ingredients MarketReport @ https://www.radiantinsights.com/research/global-active-pharmaceutical-ingredients-market-report-and-forecast-to-2021/request-sample Technological advancements in the drug manufacturing facilities are expected to provide a fillip to the market. Introduction of advanced and innovative systems for manufacturing active pharmaceutical ingredients may augur well for the global API market. To put this in perspective, in September 2017, Amazon Filters manufactured two filter housings – one made up of Polytetrafluoroethylene (PTFE) and another one using Tantalum metal deposition – exhibit phenomenal resistance to corrosive chemical damage. Soaring uptake of biopharmaceuticals can also work in favor of the market. On the other hand, strict regulatory requirements can impede market growth over the forecast period. This can be further exacerbated by the unfavorable policies pertaining to drug price control across several countries. Furthermore, high manufacturing costs of APIs can adversely affect the growth of the market. The global active pharmaceutical ingredients market is segmented on the basis of product, applications, countries, and region. Based on product, the market is divided into vaccines, biotech, and synthetic. In terms of applications, the market is classified into CNS & neurological disorders, cardiovascular disorders, and oncology. By country, the market is fragmented into Germany, United States, Japan, United Kingdom, China, and South Korea. From the geographical standpoint, the market is categorized into North America, Asia Pacific, and Europe. North America is expected to hold a prominent position in the global arena. The region is primarily driven by the presence of a robust R&D infrastructure for drug development. Rapidly growing population of geriatrics and surging demand for generics, especially in countries such as the U.S., are likely to contribute to the growth of the region. Favorable government initiatives can also have a positive impact on the regional growth. |
Archives
December 2023
Categories |